Company Quick10K Filing
Merck
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 2,596 $217,623
10-Q 2019-11-05 Quarter: 2019-09-30
10-Q 2019-08-06 Quarter: 2019-06-30
10-Q 2019-05-08 Quarter: 2019-03-31
10-K 2019-02-27 Annual: 2018-12-31
10-Q 2018-11-06 Quarter: 2018-09-30
10-Q 2018-08-07 Quarter: 2018-06-30
10-Q 2018-05-08 Quarter: 2018-03-31
10-K 2018-02-27 Annual: 2017-12-31
10-Q 2017-11-07 Quarter: 2017-09-30
10-Q 2017-08-08 Quarter: 2017-06-30
10-Q 2017-05-09 Quarter: 2017-03-31
10-K 2017-02-28 Annual: 2016-12-31
10-Q 2016-11-07 Quarter: 2016-09-30
10-Q 2016-08-08 Quarter: 2016-06-30
10-Q 2016-05-09 Quarter: 2016-03-31
10-K 2016-02-26 Annual: 2015-12-31
10-Q 2015-11-05 Quarter: 2015-09-30
10-Q 2015-08-06 Quarter: 2015-06-30
10-Q 2015-05-07 Quarter: 2015-03-31
10-K 2015-02-27 Annual: 2014-12-31
10-Q 2014-11-10 Quarter: 2014-09-30
10-Q 2014-08-07 Quarter: 2014-06-30
10-Q 2014-05-08 Quarter: 2014-03-31
10-K 2014-02-27 Annual: 2013-12-31
10-Q 2013-11-07 Quarter: 2013-09-30
10-Q 2013-08-07 Quarter: 2013-06-30
10-Q 2013-05-09 Quarter: 2013-03-31
10-K 2013-02-28 Annual: 2012-12-31
10-Q 2012-11-09 Quarter: 2012-09-30
10-Q 2012-08-07 Quarter: 2012-06-30
10-Q 2012-05-08 Quarter: 2012-03-31
10-K 2012-02-28 Annual: 2011-12-31
10-Q 2011-11-08 Quarter: 2011-09-30
10-Q 2011-08-08 Quarter: 2011-06-30
10-Q 2011-05-09 Quarter: 2011-03-31
10-K 2011-02-28 Annual: 2010-12-31
10-Q 2010-08-06 Quarter: 2010-06-30
10-Q 2010-05-07 Quarter: 2010-03-31
10-K 2010-03-01 Annual: 2009-12-31
8-K 2020-02-05 Earnings, Other Events, Exhibits
8-K 2020-01-28 Officers, Exhibits
8-K 2019-10-29 Earnings, Exhibits
8-K 2019-07-30 Earnings, Exhibits
8-K 2019-05-31 Shareholder Vote
8-K 2019-04-30 Earnings, Exit Costs, Exhibits
8-K 2019-03-07 Other Events, Exhibits
8-K 2019-02-01 Earnings, Exhibits
8-K 2019-01-29 Officers, Exhibits
8-K 2018-12-10 Officers
8-K 2018-10-25 Earnings, Other Events, Exhibits
8-K 2018-10-02 Officers
8-K 2018-09-25 Officers, Exhibits
8-K 2018-07-27 Earnings, Exhibits
8-K 2018-05-24 Shareholder Vote
8-K 2018-05-01 Earnings, Exhibits
8-K 2018-02-21 Officers
8-K 2018-02-02 Earnings, Exhibits
8-K 2018-01-23 Officers, Exhibits

Merck Financials

MRK Metrics, Comps, Filings

Annual | Quarterly

Business

Merck & Co., Inc. (Merck or the Company) is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company's operations are principally managed on a products basis and include four operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments.

The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities.

The Animal Health segment discovers, develops, manufactures and markets animal health products, including pharmaceutical and vaccine products, for the prevention, treatment and control of disease in all major livestock and companion animal species, which the Company sells to veterinarians, distributors and animal producers.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Johnson & Johnson (JNJ) 379,441 67% 14.8 11% 155,117 94,332 81,325 54,220 16,332 26,618 392,764
Pfizer (PFE) 249,913 80% 17.8 8% 156,199 96,274 53,657 42,879 12,674 16,080 286,383
Merck (MRK) 217,623 70% 14.1 11% 83,965 56,330 44,368 31,007 9,370 16,585 233,734
GlaxoSmithKline (GSK) 200,316 0% 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 0% 145,563 66,871 0 0 0 0 193,929
Abbott (ABT) 149,087 57% 22.9 4% 68,427 36,741 30,935 17,651 2,895 7,217 164,940
Eli Lilly (LLY) 106,241 77% 11.8 20% 38,666 35,809 23,229 17,810 7,843 9,937 117,668
AbbVie (ABBV) 100,912 77% 18.0 7% 57,142 65,708 32,624 25,254 4,118 7,085 127,359
Beigene (BGNE) 98,573 88% -152.1 -31% 2,150 579 434 383 -664 -642 97,723
Bristol Myers Squibb (BMY) 73,829 53% 8.4 11% 55,163 39,012 23,857 12,640 6,226 8,365 69,858
Celgene (CELG) 67,154 96% 10.4 13% 39,183 29,132 16,354 15,736 5,271 7,702 79,730
GW Pharmaceuticals (GWPH) 64,239 88% -1,554.6 -6% 843 114 114 100 -50 -41 63,656
Allergan (AGN) 54,767 85% 80.8 -4% 123,846 38,273 15,678 13,341 -5,356 939 75,841
Zoetis (ZTS) 54,569 67% 25.9 13% 10,986 8,575 6,046 4,046 1,375 2,291 59,314
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
Vertex Pharmaceuticals (VRTX) 46,842 87% 16.9 33% 7,033 1,964 3,454 2,990 2,355 2,569 43,540
Regeneron Pharmaceuticals (REGN) 35,984 0% 15.2 16% 13,174 3,418 7,237 0 2,069 2,295 34,925
Alexion Pharmaceuticals (ALXN) 28,246 71% 15.7 9% 14,568 4,404 4,499 3,191 1,334 1,835 28,827
Biomarin Pharmaceutical (BMRN) 15,774 79% 680.7 -3% 4,393 1,432 1,533 1,213 -110 24 16,336
Elanco Animal Health (ELAN) 12,085 52% 30.6 2% 8,857 3,591 3,073 1,591 144 460 14,098

Balance Sheet ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash9,31110,90013,53113,45115,6217,4418,5246,5156,0922
Accounts Receivable8,2617,6727,1846,6266,4847,0186,8737,071
Inventory8,0555,8686,2546,5356,2265,5714,7004,8665,0965,440
PP&E18,27417,08216,29716,03033,09413,13612,50712,02612,43913,291
Assets112,090105,781105,128106,132105,64598,335101,77995,37787,87282,637
Accounts Payable2,2372,3082,4621,7532,2742,6252,5332,8073,1023,318
Long-Term Debt16,07515,48215,52516,25422,63919,69926,22924,57424,35319,806
Liabilities53,03251,40550,61153,11255,88049,68857,10355,28953,53655,936
Stockholders' Equity59,05854,37654,51753,02049,76548,64744,67640,08834,33626,701
Income Statement ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue27,42845,98748,04747,26792046339,49839,80740,12242,294
Cost of Revenue13,509
Gross Profit28,785
R&D5,84510,9918,4678,1687,5037,1806,70410,12410,2089,752
SG&A8,54313,24513,73312,77611,91111,60610,3139,7629,83010,102
Tax2,2686719422,4402,3007,9001,8001,8004,1032,508
Net Income13,0249826,3926,2994,51711,9344,4593,9412,4186,193
Cash Flow ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating3,39210,82212,38310,02211,6547,86012,42110,3766,44710,922
Cash Investing3,156-3,497-2,890-6,805-3,148-374-4,758-3,2102,6794,314
Cash Financing-1,638-5,441-6,904-3,267-5,990-15,113-5,270-9,044-10,006-13,160